Respiratory Reviews in Asthma 2022
- Abstract
- Asthma is a chronic inflammatory disease of the airways characterized by varying and recurrent symptoms, reversible airway obstruction, and bronchospasm. In this paper, clinical important studies on asthma published between March 2021 and February 2022 were reviewed. A study on the relationship between asthma and chronic rhinosinusitis, bronchiectasis, and hormone replacement therapy was published. A journal on the usefulness of fractional exhaled nitric oxide for the prediction of severe acute exacerbation was also introduced. Studies on the effect of inhaler, one of the most important treatments for asthma, were published. Studies on the control of severe asthma continued. Phase 2 and 3 studies of new biologics were also published. As the coronavirus disease 2019 (COVID-19) pandemic has been prolonged, many studies have explored the prevalence and mortality of COVID-19 infection in asthma patients.
- All Author(s)
- J. H. Lee
; J. Y. Kim
; J. S. Choi
; J. O. Na
- Issued Date
- 2022
- Type
- Article
- Keyword
- Asthma; Fractional Exhaled Nitric Oxide; COVID-19; Inhaler Therapy; Biologics
- Publisher
- 대한결핵및호흡기학회
The Korean Academy of Tuberculosis and Respiratory Diseases
- ISSN
- 0378-0066
; 1738-3536
; 2005-6184
- Citation Title
- Tuberculosis and respiratory diseases
- Citation Volume
- 85
- Citation Number
- 4
- Citation Start Page
- 283
- Citation End Page
- 288
- Language(ISO)
- eng
- DOI
- 10.4046/trd.2022.0097
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/1931
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.